Join to View Full Profile
1725 W Harrison StSuite 1010Chicago, IL 60612
Phone+1 312-942-5904
Fax+1 312-942-3192
Dr. Usha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 1997 - 2000
Sutter Health/California Pacific Medical CenterResidency, Internal Medicine, 1993 - 1997
St Petersburg State Pediatric Medicine AcademyClass of 1982
Certifications & Licensure
CA State Medical License 1995 - Present
IL State Medical License 1997 - 2026
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017
Clinical Trials
- 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer Start of enrollment: 2005 Jul 01
- Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer Start of enrollment: 2006 Nov 01
- Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer Start of enrollment: 2007 Jan 01
Publications & Presentations
PubMed
- A prospective study of serum folate levels in patients with solid tumors treated with olaparib.Jamile Shammo, Laura Owczarzak, Nicole K Yun, Lois Winkelman, Sanjib Basu
The Oncologist. 2025-10-01 - Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study.Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh
Cardio-Oncology. 2024-02-06 - 2 citationsSoluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh
Cardio-Oncology. 2024-01-15
Journal Articles
- Can Chimerism Explain breast/ovarian Cancers in BRCA Non-Carriers from BRCA-Positive Families?Lydia Usha, Melody Cobleigh, PLoS One
Professional Memberships
- Member
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
